Lv5
1020 积分 2024-08-22 加入
Management of nonresponse to rituximab in rheumatoid arthritis: Predictors and outcome of re‐treatment
5个月前
已完结
Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus
5个月前
已完结
B cell depletion and inhibition in systemic lupus erythematosus
5个月前
已完结
Use of rituximab in patients with systemic lupus erythematosus: An update
5个月前
已完结
Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis
5个月前
已完结
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
5个月前
已完结
Rheumatoid arthritis: current and future trends
5个月前
已完结
Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
5个月前
已完结
B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response
5个月前
已完结
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
5个月前
已完结
皖公网安备34019202002308
